Preclinical Evaluation of Oncolytic Δγ134.5 Herpes Simplex Virus Expressing Interleukin-12 for Therapy of Breast Cancer Brain Metastases
The metastasis of breast cancer to the brain and central nervous system (CNS) is a problem of increasing importance. As improving treatments continue to extend patient survival, the incidence of CNS metastases from breast cancer is on the rise. New treatments are needed, as current treatments are li...
Saved in:
Main Authors: | James J. Cody, Pietro Scaturro, Alan B. Cantor, G. Yancey Gillespie, Jacqueline N. Parker, James M. Markert |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Breast Cancer |
Online Access: | http://dx.doi.org/10.1155/2012/628697 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cytokine-armed oncolytic herpes simplex viruses: a game-changer in cancer immunotherapy?
by: Howard L Kaufman, et al.
Published: (2024-05-01) -
Herpes Simplex Virus Hepatitis in an Immunocompetent Host Resembling Hepatic Pyogenic Abscesses
by: Carrie Down, et al.
Published: (2016-01-01) -
An Unusual Psychiatric Emergency: Herpes Simplex Encephalitis
by: H. Doyle, et al.
Published: (1994-01-01) -
Mucosal Herpes Immunity and Immunopathology to Ocular and Genital Herpes Simplex Virus Infections
by: Aziz Alami Chentoufi, et al.
Published: (2012-01-01) -
Advances in preclinical and clinical studies of oncolytic virus combination therapy
by: Wenlong Du, et al.
Published: (2025-02-01)